Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

LABS

VIVO Cannabis (LABS)

VIVO Cannabis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:LABS
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202422h30PR Newswire (US)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
08/05/202422h30PR Newswire (Canada)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
27/03/202415h54PR Newswire (Canada)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202415h54PR Newswire (US)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202411h30PR Newswire (US)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
27/03/202411h30PR Newswire (Canada)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
25/03/202411h30PR Newswire (Canada)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
25/03/202411h30PR Newswire (US)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
22/03/202411h30PR Newswire (US)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
22/03/202411h30PR Newswire (Canada)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
07/02/202412h30PR Newswire (US)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
07/02/202412h30PR Newswire (Canada)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
22/12/202313h00PR Newswire (US)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
22/12/202313h00PR Newswire (Canada)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
14/11/202313h15PR Newswire (US)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
14/11/202313h15PR Newswire (Canada)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
08/11/202323h01PR Newswire (US)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
08/11/202323h01PR Newswire (Canada)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
25/10/202313h00PR Newswire (US)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
25/10/202313h00PR Newswire (Canada)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
02/10/202313h00PR Newswire (US)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
02/10/202313h00PR Newswire (Canada)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
27/09/202313h15PR Newswire (Canada)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
27/09/202313h15PR Newswire (US)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
20/09/202313h00PR Newswire (US)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
20/09/202313h00PR Newswire (Canada)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
05/09/202313h39PR Newswire (US)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
05/09/202313h39PR Newswire (Canada)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
31/08/202314h02PR Newswire (US)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
31/08/202314h02PR Newswire (Canada)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
 Showing the most relevant articles for your search:TSX:LABS